BACKGROUND: The relations between chronic kidney disease (CKD) and incident heart failure remain unclear. METHODS AND RESULTS: We related CKD to incident nonfatal heart failure and cardiovascular (CVD) death (as separate and combined end points) in 10 181 male participants (mean age, 67 years). Kidney function was assessed by estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease equation in clinically relevant categories of <60 and ≥60 mL · min(-1) · 1.73 m(-2) (referent) and <45, 45 to 60, 60 to 90, and ≥90 mL · min(-1) · 1.73 m(-2) (referent). During follow-up (mean, 10.1 years; range, 0.03 to 12.2), 439 developed heart failure and 832 had CVD death/heart failure. In multivariable models, men with eGFR <60 mL · min(-1) · 1.73 m(-2) had a 2-fold risk of heart failure (95% confidence interval, 1.62 to 2.56, P<0.0001) compared with referent category. The hazard ratio (with corresponding 95% confidence interval) for development of heart failure according to eGFR categories of 60 to 90, 45 to 60, and <45 mL · min(-1) · 1.73 m(-2) compared with referent category were 1.24 (0.98 to 1.56), 2.58 (1.91 to 3.49), and 1.52 (0.92 to 2.76), respectively. In the analyses restricted to subgroup of nondiabetic individuals and normotensive individuals at baseline (n=7545), men with eGFR <60 mL · min(-1) · 1.73 m(-2) had a 2.2-fold risk of heart failure (95% confidence interval, 1.66 to 2.95), compared with men with eGFR ≥60 mL · min(-1) · 1.73 m(-2). Additionally, risk of heart failure or CVD death was >2.5-fold higher among individuals with eGFR 45 to 60 and <45 mL · min(-1) · 1.73 m(-2), compared with referent category. CONCLUSIONS: Moderate level of CKD, even in absence of diabetes and hypertension at baseline, is associated with a higher risk of development of heart failure and CVD death/heart failure in men.
BACKGROUND: The relations between chronic kidney disease (CKD) and incident heart failure remain unclear. METHODS AND RESULTS: We related CKD to incident nonfatal heart failure and cardiovascular (CVD) death (as separate and combined end points) in 10 181 male participants (mean age, 67 years). Kidney function was assessed by estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease equation in clinically relevant categories of <60 and ≥60 mL · min(-1) · 1.73 m(-2) (referent) and <45, 45 to 60, 60 to 90, and ≥90 mL · min(-1) · 1.73 m(-2) (referent). During follow-up (mean, 10.1 years; range, 0.03 to 12.2), 439 developed heart failure and 832 had CVD death/heart failure. In multivariable models, men with eGFR <60 mL · min(-1) · 1.73 m(-2) had a 2-fold risk of heart failure (95% confidence interval, 1.62 to 2.56, P<0.0001) compared with referent category. The hazard ratio (with corresponding 95% confidence interval) for development of heart failure according to eGFR categories of 60 to 90, 45 to 60, and <45 mL · min(-1) · 1.73 m(-2) compared with referent category were 1.24 (0.98 to 1.56), 2.58 (1.91 to 3.49), and 1.52 (0.92 to 2.76), respectively. In the analyses restricted to subgroup of nondiabetic individuals and normotensive individuals at baseline (n=7545), men with eGFR <60 mL · min(-1) · 1.73 m(-2) had a 2.2-fold risk of heart failure (95% confidence interval, 1.66 to 2.95), compared with men with eGFR ≥60 mL · min(-1) · 1.73 m(-2). Additionally, risk of heart failure or CVD death was >2.5-fold higher among individuals with eGFR 45 to 60 and <45 mL · min(-1) · 1.73 m(-2), compared with referent category. CONCLUSIONS: Moderate level of CKD, even in absence of diabetes and hypertension at baseline, is associated with a higher risk of development of heart failure and CVD death/heart failure in men.
Authors: Guruprasad Manjunath; Hocine Tighiouart; Josef Coresh; Bonnie Macleod; Deeb N Salem; John L Griffith; Andrew S Levey; Mark J Sarnak Journal: Kidney Int Date: 2003-03 Impact factor: 10.612
Authors: Linda F Fried; Michael G Shlipak; Casey Crump; Anthony J Bleyer; John S Gottdiener; Richard A Kronmal; Lewis H Kuller; Anne B Newman Journal: J Am Coll Cardiol Date: 2003-04-16 Impact factor: 24.094
Authors: Claudia U Chae; Christine M Albert; Robert J Glynn; Jack M Guralnik; Gary C Curhan Journal: Am J Cardiol Date: 2003-09-15 Impact factor: 2.778
Authors: Guruprasad Manjunath; Hocine Tighiouart; Hassan Ibrahim; Bonnie MacLeod; Deeb N Salem; John L Griffith; Josef Coresh; Andrew S Levey; Mark J Sarnak Journal: J Am Coll Cardiol Date: 2003-01-01 Impact factor: 24.094
Authors: Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson Journal: Circulation Date: 2003-10-28 Impact factor: 29.690
Authors: Matthew Nayor; Martin G Larson; Na Wang; Rajalakshmi Santhanakrishnan; Douglas S Lee; Connie W Tsao; Susan Cheng; Emelia J Benjamin; Ramachandran S Vasan; Daniel Levy; Caroline S Fox; Jennifer E Ho Journal: Eur J Heart Fail Date: 2017-02-20 Impact factor: 15.534
Authors: David D McManus; Jane S Saczynski; Jeanine A Ward; Khushleen Jaggi; Peter Bourrell; Chad Darling; Robert J Goldberg Journal: J Atr Fibrillation Date: 2012-06-15
Authors: James S Floyd; Robert Wellman; Sharon Fuller; Nisha Bansal; Bruce M Psaty; Ian H de Boer; Delia Scholes Journal: Clin J Am Soc Nephrol Date: 2016-08-09 Impact factor: 8.237